CRYOPORT, INC. Company Profile
CRYOPORT, INC. as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Current registered country: Value Nevada, United States.
- Country of operation (business address): Value United States.
- Business address: Value 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, Tennessee, 37027, United States.
- Mailing address: Value 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, Tennessee, 37027, United States.
| Measure | Value |
|---|---|
| Current registered country | Nevada, United States SEC EDGAR state of incorporation NV |
| Country of operation (business address) | United States |
| Business address | 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, Tennessee, 37027, United States |
| Mailing address | 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, Tennessee, 37027, United States |
| Industry (SIC) | 2834 Pharmaceutical Preparations |
| Fiscal year end | 12-31 |
| Filer category | Accelerated filer |
| Listed stock (Section 12(b)) | Common Stock, $0.001 par value · CYRX · NASDAQ 10-Q filed 2026-08-06 cover |
| Shell company | No 10-Q filed 2026-08-06 cover |
| Smaller reporting company | No 10-Q filed 2026-08-06 cover |
| Emerging growth company | No 10-Q filed 2026-08-06 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-06 cover |
| Well-known seasoned issuer | No 10-K filed 2026-03-05 cover |
| Voluntary filer | No 10-K filed 2026-03-05 cover |
| Former names | CRYOPORT SYSTEMS INC (2005-10-20 to 2005-10-20) |
| First EDGAR filing | 2005-10-20 (10SB12G) |
| SEC CIK | 1124524 |
| EIN | 880313393 |
| Phone | (949) 232-1900 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |